The total return over the past 12 months is -95.10% vs. +16.94% for the S&P 500. So far it's up -92.41% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (95.10%) | (73.35%) | (72.60%) | N/A | N/A | N/A |
| Total Return CAGR | (95.10%) | (73.35%) | (72.60%) | N/A | N/A | N/A |
| Revenue CAGR | +45.21% | +10.60% | +7.52% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Vivos Therapeutics, Inc. (VVOS)
| Year | Start price | End price | VVOS Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.03 | $0.15 | (92.41%) | +14.51% | (106.92%) |
| 2025 | $4.29 | $2.03 | (52.68%) | +17.72% | (70.40%) |
| 2024 | $12.44 | $4.29 | (65.51%) | +24.89% | (90.40%) |
| 2023 | $10.05 | $12.44 | +23.78% | +26.19% | (2.41%) |
| 2022 | $56.25 | $10.05 | (82.13%) | (18.17%) | (63.96%) |
| 2021 | $147.75 | $56.25 | (61.93%) | +28.74% | (90.67%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
